Loading...
TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
In the past decades, chemotherapy has resulted in improved outcomes for patients with osteosarcoma. However, resistance to chemotherapy often leads to poor prognoses. Cisplatin is a standard drug for osteosarcoma therapy, and chemoresistance to cisplatin in osteosarcoma limits the effectiveness of c...
Na minha lista:
| Udgivet i: | Int J Mol Med |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6108886/ https://ncbi.nlm.nih.gov/pubmed/30015899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2018.3753 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|